Macrene Alexiades-Armenakas, MD
Dermatology · New York, NYNPI 1851342786
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $204,371 of the $290,731 with a category attached, or 70.3%. 5 manufacturers reported payments, led by Lumenis Ltd. at 47.3% of the total. Reporting peaked in 2020 at $85,257 and has fallen 94.9% since, to $4,318 in 2025. Among dermatology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $4614.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis Ltd.$137K
- Lumenis BE LTD$93K
- AbbVie$59K
- Revance Therapeutics, Inc.$2K
- Galderma Laboratories, L.p.$182
Across 83 payments — averaging $4128.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$343K
What the payments were for
- Consulting fees$79,59127%
- Speaking & faculty fees$204,37170%
- Travel & lodging$2,6461%
- Food & beverage$4,0991%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis Ltd. | 6 | $137,435 |
| Lumenis BE LTD | 4 | $92,566 |
| AbbVie(2 entities) | 51 | $58,547 |
| Revance Therapeutics, Inc. | 1 | $2,000 |
| Galderma Laboratories, L.p. | 1 | $182 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NuEra$52,436
- Lumenis Pulse 120H$46,685
- New Era$33,580
- BOTOX COSMETIC$25,233
- BOTOX$7,849
- M22$2,050
- DAXXIFY$2,000
How this compares
$290,731 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Ir-DrDoxycycline Monohydrate | 16 | $8,800 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.